Current prostate specific antigen (PSA) testing "may not effectively target testing to those most likely to benefit, raising concerns about overtesting" warn researchers from the University of Oxford ...

Investigators conducted a meta-analysis of 4 randomized controlled trials including a total of more than 1000 men with prostate cancer.

This article was reviewed by Darragh O’Carroll, MD. PSA and Testosterone: Are They Linked? Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting ...

CUYAHOGA COUNTY, Ohio — Prostate cancer continues to be one of the most commonly diagnosed cancers among men in Cuyahoga County, underscoring the need for early detection and routine screening, ...

Despite previous research pointing to a substantial increase in global prostate cancer mortality in the future, Isaac Y. Kim, ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...